Lifecare aktie (LIFE) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Morgonkollen: Aktuella händelser du bör ha koll på

Pressmeddelanden från Lifecare

 Bevaka pressreleaser
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

LIFE: Lifecare ASA Q3 2024

Bergen, Norway, 13 November 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next ge...

MFN • 13 Nov 07:00

Lifecare ASA Q3 2024 presentation

Lifecare ASA will release its third quarter 2024 results on Wednesday 13 November 2024 at 07:00 a.

MFN • 05 Nov 10:40

Lifecare - Sanofi Product Development Agreement Update

Bergen, Norway, 29 October 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluc...

MFN • 29 Oct 07:00

Lifecare ASA listed on Euronext Oslo Børs

Bergen, Norway, 22 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 22 Oct 10:00

LIFE – Lifecare ASA uplisting to Euronext Oslo Børs is approved

Bergen, Norway, 21 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 21 Oct 17:27

Lifecare ASA: Share capital increase registered

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") on 15 October 2024 regarding the successful result...

MFN • 18 Oct 10:59

Lifecare ASA: Public retail offering successfully placed

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 15 Oct 23:05

Lifecare ASA: Last day of application period

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 15 Oct 07:00

Lifecare presentation at the Diabetes Technology Meeting 2024.

Bergen, Norway, October 14, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glu...

MFN • 14 Oct 07:05

Lifecare ASA: Application deadline for applicants using Nordnet webservice

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN O...

MFN • 14 Oct 07:00

Lifecare ASA: Mandatory notification of trade

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 8 October 2024, regarding the commencement...

MFN • 10 Oct 15:10

LIFE – Study protocol has been finalized for submission to regulatory authorities

Bergen, Norway, 10 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 10 Oct 07:00

Lifecare ASA: Ex. consolidation (reverse split) of shares and warrants today

Reference is made to the stock exchange announcement made on 27 September 2024 with key information regarding the consolidation (reverse spl...

MFN • 01 Oct 07:00

Lifecare ASA: Share consolidation (reverse split) and change of par value

Reference is made to the extraordinary general meeting in Lifecare ASA (the "Company") held on 17 September 2024, where it was resolved to c...

MFN • 30 Sep 17:31

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants and change of ISIN for the shares

Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Co...

MFN • 27 Sep 17:22

Lifecare ASA: Key information relating to the consolidation (reverse split) of shares and warrants

Reference is made to the extraordinary general meeting of the Company held on 17 September 2024, where it was resolved to consolidate the Co...

MFN • 26 Sep 07:00

Lifecare ASA: Re-purchase of shares and warrants completed

Reference is made to the stock exchange announcement made by Lifecare ASA (the "Company") earlier today, 25 September 2024, regarding the re...

MFN • 25 Sep 12:15

Lifecare ASA: Re-purchase of shares and warrants

Reference is made to the contemplated consolidation of shares in Lifecare ASA (the "Company") in a ratio of 13:1, as resolved by the extraor...

MFN • 25 Sep 07:00

Minutes from Extraordinary General Meeting

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 17 September 2024.

MFN • 17 Sep 11:00

LIFE – Successfully completes the first patient in the longevity trial after three months

Bergen, Norway, 11 September 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Contin...

MFN • 11 Sep 07:00

LIFECARE ASA: Extraordinary General Meeting

Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), will hold an Extraord...

MFN • 03 Sep 14:31

Correction: LIFE: Lifecare ASA Q2 2024

Bergen, Norway, 27 August 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next gener...

MFN • 30 Aug 15:50

LIFE: Lifecare ASA Q2 2024

Bergen, Norway, 27 August 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next gener...

MFN • 27 Aug 07:00

Lifecare ASA Q2 2024 presentation

Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august 2024 at 07:00 a.

MFN • 22 Aug 16:30

LIFE – Successfully completed nine weeks of longevity trials

Bergen, Norway, 21 August 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuou...

MFN • 21 Aug 07:00

LIFE: Strategic cooperation to make glucose data more accessible

Bergen, Norway, August 13, 2024: Lifecare ASA, a clinical stage medical sensor company developing the next generation Continuous Glucose Mon...

MFN • 13 Aug 07:00

LIFE – Successfully completed four weeks of longevity trials

Bergen, Norway, 17 July 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous ...

MFN • 17 Jul 08:00

Lifecare ASA: Share capital increase

Reference is made to the stock exchange announcement published by Lifecare ASA ("Lifecare" or the "Company") on 14 June 2024 regarding the f...

MFN • 05 Jul 10:07

LIFE: Cleanroom arrived in Hamburg

Bergen, Norway, July 2, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose...

MFN • 02 Jul 08:00

LIFE: Successfully completed first week of longevity trials

Bergen, Norway, 27 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous ...

MFN • 27 Jun 08:00

Lifecare ASA: Information about the warrants issued in connection with the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 27 Jun 07:00

Lifecare ASA: Share capital increase and warrants registered

Reference is made to the stock exchange announcement published by Lifecare ASA ("Lifecare" or the "Company") on 14 June 2024 regarding the f...

MFN • 25 Jun 14:47

LIFE – Longevity trials in dogs starts today

Bergen, Norway, 18 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous ...

MFN • 18 Jun 08:00

LIFE: Satisfied with the final results of the Rights Issue

Bergen, Norway, 14 June, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous...

MFN • 14 Jun 12:17

Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 14 Jun 12:11

Lifecare ASA: Preliminary results of the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 13 Jun 19:21

LIFE – Successful in-vitro quality testing of sensor

Bergen, Norway, June 13th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 13 Jun 14:33

Lifecare ASA: Last day of the Subscription Period in the Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 13 Jun 08:00

Lifecare ASA: Mandatory notification of trade

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 30 May 2024, regarding the commencement of...

MFN • 12 Jun 10:58

LIFE – Improved read out distance for sensor – preparing for longevity trials in dogs

Bergen, Norway, June 10th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 10 Jun 08:25

Lifecare ASA: Mandatory notification of trade

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 30 May 2024, regarding the commencement of...

MFN • 07 Jun 13:21

Lifecare ASA: Last day of trading in Subscription Rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 07 Jun 08:00

LIFE – Sterilization protocol ready for the production line

Bergen, Norway, June 6th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuou...

MFN • 06 Jun 08:00

LIFE: Lifecare ASA has filed application for a new patent

Bergen, Norway, June 4th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuou...

MFN • 04 Jun 08:00

Lifecare ASA: Mandatory notification of trade by primary insiders and close associates

Reference is made to the stock exchange announcement published by Lifecare ASA (the "Company") on 30 May 2024, regarding the commencement of...

MFN • 30 May 13:45

LIFE – Lifecare CEO presents at Redeye Growth Day 2024

Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter will participate at Redeye Growth Day 2024 and present the late...

MFN • 30 May 08:30

Lifecare ASA: Commencement of the subscription period for the Rights Issue and start of trading in Subscription Rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 30 May 08:00

Lifecare ASA: FAQ regarding Rights Issue

Reference is made to the previous stock exchange announcements published by Lifecare ASA ("Lifecare" or the "Company") regarding the partial...

MFN • 29 May 13:45

Lifecare ASA: Registration of national prospectus for the preferential Rights Issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 29 May 13:15

LIFE – Ex. Subscription Rights today

LIFE – Ex.

MFN • 21 May 08:00

Minutes from Extraordinary General Meeting

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 16 May 2024.

MFN • 16 May 13:25

Lifecare ASA: Updated key information relating to the preferential rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 15 May 20:18

LIFE – Conversion to a public limited liability company registered

Bergen, Norway, 29 April 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous...

MFN • 13 May 08:00

Lifecare Q1 2024 Report – From preparations phase to pilot production

Bergen, Norway, May 5th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next genera...

MFN • 08 May 08:00

Lifecare Q1 2024 report and webcast

Lifecare AS will present Q1 2024 financial and operational status in a webcast Wednesday 8 May.

MFN • 07 May 08:00

Extraordinary General Meeting

Lifecare AS will hold an Extraordinary General Meeting on May 16th, 2024, at 10:00 (CET).

MFN • 02 May 20:41

Minutes from Annual General Meeting

The Annual General Meeting of Lifecare AS was convened as a hybrid meeting on 30 April 2024.

MFN • 30 Apr 15:40

LIFE – Lifecare becomes majority shareholder in RemovAid

Bergen, Norway, 29 April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose...

MFN • 29 Apr 08:00

LIFE – Strategic investment in RemoveAid AS

Bergen, Norway, 26th April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluco...

MFN • 26 Apr 13:29

Correction: Lifecare AS: Proposed partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 26 Apr 10:32

LIFE: Lifecare BoD propose a partially underwritten rights issue

Bergen, Norway, 26 April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose...

MFN • 26 Apr 08:00

Lifecare AS: Key information relating to the preferential rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 25 Apr 20:01

Lifecare AS: Proposed partially underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATI...

MFN • 25 Apr 20:00

Annual General Meeting

Lifecare AS will hold a General Meeting on April 30th, 2024, at 10:00 (CET).

MFN • 16 Apr 11:32

LIFE: Presentation at MARSS 2024

Lifecare’s Dr. Preeti Sharma is invited as a speaker to present a paper at International Conference on Manipulation, Automation and Robotics...

MFN • 16 Apr 08:00

LIFE - Lifecare’s Annual Report 2023

Bergen, Norway, April 9th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next gene...

MFN • 09 Apr 23:03

LIFE - Breakthrough: Reaching target for pilot production

Bergen, Norway, 3rd April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucos...

MFN • 03 Apr 07:55

LIFE: The European Patent Office issues a new Lifecare patent

Bergen, Norway, March 21st, 2024: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuo...

MFN • 21 Mar 08:00

LIFE: Poster presentations at ATTD 2024 in Firenze

Today starts the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2024) in Firenze.

MFN • 06 Mar 08:00

LIFE: Placing purchase order for cleanroom

Bergen, Norway, 5 March 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose ...

MFN • 05 Mar 08:00

Lifecare Q4 2023 Report – Steady course

Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next ...

MFN • 27 Feb 08:00

Lifecare Q4 2023 report and webcast

Lifecare AS will present Q4 2023 financial and operational status in a webcast Tuesday 27 February.

MFN • 26 Feb 08:00

LIFE – Lifecare will prepare for uplisting to the main list on Oslo Stock Exchange

Bergen, Norway, February 21st, 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous G...

MFN • 21 Feb 08:00

LIFE – Progress towards pilot production and automatization

Bergen, Norway, 14 February 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluc...

MFN • 14 Feb 08:00

LIFE – Appointment of Production Manager

Bergen, Norway, 1 February 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluco...

MFN • 01 Feb 08:00

Stock Exchange Notification – Lifecare – Appointment of CFO

Bergen, Norway, 23 January 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Gluco...

MFN • 23 Jan 08:00

LIFE – Successfully ISO 13485 certified

Bergen, Norway, January 9th, 2024: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continu...

MFN • 09 Jan 08:00

LIFE: Letter from CEO - Happy New Year

The technology development and company progress were fantastic in 2023.

MFN • 03 Jan 08:00

LIFE: Prof. Dr. Tony James joining Lifecare's Scientific Advisory Board

Professor Dr. Tony James will join Lifecare's Scientific Advisory Board.

MFN • 19 Dec 2023 08:00

LIFE: CSO - Switch from consultancy agreement to employee

Bergen, Norway, December 15th, 2023, Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Conti...

MFN • 15 Dec 2023 17:53

LIFE: Notofication of trade by party closely related to primary insider

Bergen, Norway, December 15th, 2023. Islay Ventures GmbH (“IV”) a company wholly owned and controlled by Lifecare CSO Prof.

MFN • 15 Dec 2023 17:45

LIFE: Final purchase order for automated production components - micro-fluidic handling and dispensing devices

Bergen, Norway, December 13th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Conti...

MFN • 13 Dec 2023 08:00

LIFE: Purchase order on scanning electron microscope from Zeiss

Bergen, Norway, November 28th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Conti...

MFN • 28 Nov 2023 08:00

LIFE: Successful ISO 13485 audit

Bergen, Norway, November 20th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Conti...

MFN • 20 Nov 2023 08:00

LIFE: Lifecare Q3 2023 Report

Bergen, Norway, November 14th, 2023: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next ...

MFN • 14 Nov 2023 08:00

Lifecare Q3 2023 report and webcast

Lifecare AS will present Q3 2023 financial and operational status in a webcast Tuesday 14 November.

MFN • 13 Nov 2023 08:00

LIFE: The European Patent Office intends to issue new Lifecare patent

Bergen, Norway, November 8th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Contin...

MFN • 08 Nov 2023 08:00

LIFE: Lifecare receives regulatory approval to start LFC-SEN-002

Bergen, Norway, November 7th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Contin...

MFN • 07 Nov 2023 08:00

Lifecare – New share capital registered

Reference is made to the stock exchange announcement by Lifecare AS (the "Company") published on 19 October 2023, announcing the successful ...

MFN • 06 Nov 2023 15:37

Lifecare – Valuation Report of the Sencell technology (CGM) for diabetes

Bergen, Norway, November 1st, 2023: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next g...

MFN • 01 Nov 2023 08:00